Molecular Biology Pharma Companies Pharmaceuticals 
Drug Discovery World
MAY 6, 2024
Europe is traditionally a life sciences powerhouse, with a strong tradition in pharmaceutical discovery. The oldest, still active pharmaceutical company worldwide, Merck, started life in 1668 in Darmstadt, Germany. share of global pharma revenues, according to analysts Statistica 1. In 2022, the continent held a 22.4%
Drug Discovery World
MAY 1, 2024
This is reflected in collaboration and investment patterns; in 2023, Antiverse, a biotechnology company developing a computational antibody drug discovery platform, raised seed funding totalling £1.4 million, comprising new investment and match funding from the UKI2S Innovate Accelerator.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Vial
MARCH 1, 2024
Introduction Contract research organizations (CROs) are essential in pharmaceutical research and development (R&D). A 2022 survey by McKinsey found that emerging biotech companies are less satisfied with their CROs than large pharma companies and reported the feeling of being underserved.
Drug Target Review
APRIL 19, 2024
Sibylla’s scientific founders come from very different scientific fields that do not usually speak to each other, such as theoretical physics, molecular biology and pharmaceutical chemistry. And so, I have been the managerial co-founder and CEO of Sibylla since 2017. Identifying new drugs is an extremely complex project.
Elrig
APRIL 29, 2024
With a background in Bioinformatics and Computational Biology, she has a keen interest in using technology to solve problems in healthcare and medicine. Having a combination of computational skills & scientific knowledge such as molecular biology, genomics is also important. big pharma or startups/spin off?
Drug Discovery World
NOVEMBER 15, 2022
As such, the synthesis of DNA oligonucleotides for routine molecular biology applications is often outsourced to service provider companies that operate DNA synthesisers to meet these demands. . We are even seeing some companies going completely ‘lab-free’, outsourcing the entire workflow,” says Dr Leproust. “By
Drug Discovery World
AUGUST 16, 2022
In recent years, governments, institutes, pharma companies, and funding bodies have taken significant measures to proactively address cancer disparities. However, these social categories are rather arbitrary and don’t necessarily correspond to the underlying molecular biology of the patient, risking misguided clinical care.
Expert insights. Personalized for you.
147 
Let's personalize your content